Heparin-induced thrombocytopenia;Heparin-induzierte thrombozytopenie

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 33, Issue 7, 1998, Pages 411-416

  Brenske, M ^a   Tarnow, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Heparin; Heparin induced thrombocytopenia; Thrombocytopenia; Thrombosis, complication

Indexed keywords

DANAPAROID; HEPARIN; THROMBOCYTE FACTOR 4;

ANTICOAGULATION; COMPLEX FORMATION; DRUG EFFECT; DRUG INDUCED DISEASE; HUMAN; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0031857932     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994277     Document Type: Review

References (48)

1. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D: Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb. Haemostasis 1992; 68: 95 - 96
2. Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meyer D: Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb. Haemostasis 1995; 73: 21 - 28
3. Amiral J, Wolf M, Fischer AM, Boyer-Neumann C, Vissac AM, Meyer D: Pathogenecity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br. J. Haematol. 1996; 92: 954 - 959
4. Calhoun BC, Hesser JW: Heparin-associated antibody with pregnancy: Discussion of two cases. Am. J. Obstet. Gynecol. 1987; 156: 964 - 966
5. Cines DB, Tomaski A, Tannenbaum S: Immune endothelial-cell injury in heparin associated thromboxytopenia. N. Engl. J. Med. 1987; 316: 581 - 589
6. Chang JC: Review: Postoperative thrombocytopenia: With etiologic, diagnostic, and therapeutic consideration. Am. J. Med. Sci. 1996; 311: 96 - 105
7. Chong BH: Heparin-induced thrombocytopenia. Br. J. Haematol. 1995; 89: 431 - 439
8. Chong BH, Pitney WR, Castaldi PA: Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet 1982; 2: 1246 - 1249
9. Cohen JI, Cooper MR, Greenberg CS: Streptokinase therapy of pulmonary emboli with heparin-associated thrombocytopenia. Arch. Intern. Med. 1985; 145: 1725 - 1726
10. Demers C, Ginsberg JS, Brill-Edwards P, Panju A, Warkentin TE, Anderson DR, Turner C, Kelton JG: Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood 1991; 78: 2194 - 2197
11. Dieck JA, Rizo-Patron C, Unisa A, Mathur V, Massumi GA: A new manifestation and treatment alternative for heparin-induced thrombosis. Chest 1990; 98: 1524 - 1526
12. Doherty DC, Ortel TL, De Bruijn N, Greenberg CS, Van Trigt P: Heparin-free cardiopulmonary bypass: First reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass. Anaesthesiology 1990; 73: 562 - 565
13. Eichinger S, Kyrle PA, Brenner B, Wagner B, Kapiotis S, Lechner K, Korninger HC: Thrombocytopenia associated with low-molecular-weight heparin. Lancet 1991; 337: 1425 - 1426
14. Erni J, Frey HR, Locher G: Das heparin-induzierte Thrombose-Thrombozytopenie-Syndrom. Dtsch. med. Wschr. 1987; 112: 801 - 805
15. Greinacher A: Antigen generation in heparin-associated thrombocytopenia: The nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin. Thromb. Hemost. 1995; 21: 106 - 116
16. Greinacher A: Heparin-induzierte Thrombozytopenien. Internist 1996; 37: 1172 - 1178
17. Greinacher A: Die Heparin-induzierte Thrombozytopenie. Wien. Klin. Wochenschr. 1997; 109: 343 - 345
18. Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel V, Müller-Eckardt C: Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelat aggregation test, heparininduced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 1994; 34: 381 - 385
19. Greinacher A, Michels I, Kiefel C, Müller-Eckardt: A rapid and sensitive test for diagnosing heparin-associated thrombocytopnia. Thromb. Haemost. 1991: 66: 734 - 736
20. Greinacher A, Volpel H, Pötzsch B: Recombinant hirudin in the treatment of patients with heparin-induced thrombocytopenia (HIT). Blood 1996; 88 (Suppl. 1): 281 a (abstract)
21. Hach-Wunderle V, Kainer K, Krug B, Müller-Berghaus G, Pötzsch B: Heparin-associated thrombosis despite normal platelet counts. Lancet 1994; 344: 469-470
22. Hartman AR, Hood MR, Anagnostopoulos CE: Phenomenon of heparin-induced thrombocytopenia associated with skin necrosis. J. Vasc. Surg. 1988; 7: 781 - 784
23. Kappa JR, Fisher CA, Berkowitz HD, Cottrell ED, Addonizio JR: VP: Heparin-induced platelet activation in sixteen surgical patients: Diagnosis and management. J. Vasc. Surg. 1987; 5: 101 - 109
24. Kelton JG, Smith JW, Warkentin TE, Hayward CPM, Denomme GA, Horsewood P: Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994; 83: 3232 - 3239
25. King DJ, Kelton JG: Heparin-associated thrombocytopenia. Ann. Intern. Med. 1984; 100: 535 - 540
26. Königer J, Greinacher A, Müller-Beißenhirtz, Strosche H: Heparin-assoziierte Thrombozytopenie durch niedermolekulare Heparine. Unfallchirurg. 1995; 98: 49 - 51
27. Kraenzler EJ, Starr NJ: Heparin-associated thrombocytopenia: Management of patients for open heart surgery. Case reports describing the use of iloprost. Anesthesiology 1988; 69: 964 - 967
28. Leroy J, Leclerc MH, Delahousse B, Guerois C, Foloppe P, Gruel Y, Toulemonde F: Treatment of heparin associated thrombocytopenia and thrombosis with low molecular weight heparin (CY216). Semin. Thromb. Hemost. 1985; 11: 326 - 329
29. Magnani HN: Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with orgaran (Org 10172). Thromb. Haemost. 1993; 70: 554 - 561
30. Matsuo T, Kario K, Chikahira Y, Nakao K, Yamada T: Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor. Br. J. Haematol. 1992; 82: 627 - 629
31. Murphy KD, McCrohan G, Demarta DA, Shirodkar NB, Known OJ, Chopra PS: The heparin-induced thrombocytopenia and thrombosis syndrome: Treatment with intraarterial urokinase and systemic platelet aggregation inhibitors. Cardiovasc. Intervent. Radiol. 1996; 19: 123 - 127
32. Nand S, Robinson JA: Plasmapheresis in the management of heparin-associated thrombocytopenia with thrombosis. Am. J. Hematol. 1988; 28: 204 - 206
33. Pötzsch B, Greinacher A, Riess FC, Madlener K, Völpel H, Müller-Berghaus G: Recombinant hirudin as anticoagulant in cardiac surgery: Experiences with eleven patients. Ann. Hematol. 1996; 72 (Supplement): A4 (abstract)
34. Rhodes GR, Dixon RH, Silver D: Heparin induced thrombocytopnia: Eight cases with thrombotic-hemorrhagic complications. Ann. Surg. 1977; 186: 752 - 758
35. Riess FC, Löwer C, Seelig C, Bleese N, Kormann J. Müller-Berghaus C, Pötzsch B: Recombinant hirudin is a new anti-coagulant during cardiac operations instead of heparin: Successful for aortic valve replacement in man. J. Thorac. Cardiovasc. Surg. 1995; 110; 265 - 267
36. Schiele F, Vuillemenot A, Kramarz P, Kiffer Y, Anguenot T, Bernard Y, Bassand JP: Use of recominant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia. Am. J. Hematol. 1995; 50: 20 - 25
37. Schmitt BP, Adelman B: Heparin-associated thrombocytopenia: A critical review and pooled analysis. Am. J. Med. Sci. 1993; 305: 208 - 215
38. Sheridan D, Carter C, Kelton JG: A diagnostic test for heparininduced thrombocytopenia. Blood 1986; 67: 27 - 30
39. Sobel M, Adelman B, Szentpetery S, Huffman M, Posner MP, Jenvey W: Surgical management of heparin-associated thrombocytopenia: Strategies in the treatment of venous and arterial thrombembolism. J. Vase. Surg. 1988; 8: 395 - 401
40. Spiekermann BF, Lake CL, Rich GF, Humphries JE: Normal activated clotting time despite adequate anticoagulation with ancrod in a patient with heparin-associated thrombocytopenia and thrombosis undergoing cardiopulmonary bypass. Anesthesiology 1994; 80: 686 - 688
41. Teasdale SJ, Zulys VY, Mycyk T, Baird RJ. Glynn MFX: Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis. Ann. Thorac. Surg. 1989; 48: 712 - 713
42. Vender JS, Matthew EB, Silverman IM, Konowitz H, Dau PC: Heparin-associated thrombocytopenia: Alternative managements. Anesth. Analg. 1986; 65: 520 - 522
43. Visentin GP, Ford SE, Scott JP, Aster RH: Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J. Clin. Infest. 1994; 93: 81 - 88
44. Warkentin TE, Hayward CPM, Boshkov LK, Santos AV, Sheppard JAI, Bode AP, Kelton JG: Sera from patients with heparin-induced thrombocytopenia generate platelet derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994; 84: 3691 - 3699
45. Warkentin TE, Levine MN, Hirsch J, Horsewood P, Roberts RS, Gent M, Kelton JG: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N. Engl. J. Med. 1995; 332: 1330 - 1335
46. Warkentin TE, Kelton JG: A 14-year study of heparin-induced thrombocytopenia. Am. J. Med. 1996; 101: 502 - 507
47. Weissmann RE, Tobin RW: Arterial embolism occurring during systemic heparin therapy. Arch. Surg. 1958; 76: 219 - 227
48. Zulys VJ, Teasdale SJ, Michel ER, Skala RA, Keating SE, Viger JR, Glynn MFX: Ancrod (Arvin®) as an alternative to heparin anticoagulation for cardiopulmonary bypass. Anesthesiology 1989; 71: 870 - 877